Ac-LEHD-AFC

What We Offer

Ac-LEHD-AFC

Ac-LEHD-AFC | CAS 210345-03-2

Catalog Number A18-0001
Category Fluorescent Enzyme Substrates
Molecular Formula C33H38F3N7O11
Molecular Weight 765.69
Inquiry

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Product Introduction

Ac-LEHD-AFC is a fluorogenic substrate that features a peptide sequence conjugated to 7-amino-4-trifluoromethylcoumarin (AFC), a widely recognized fluorophore. Upon enzymatic cleavage by caspase family proteases, the non-fluorescent substrate releases the highly fluorescent AFC, allowing for the detection and quantification of protease activity in biochemical assays. This compound is commonly utilized in apoptosis research, where it supports the monitoring of caspase activation through its distinct excitation and emission properties.

  • Chemical Information

  • Product Specification

  • Application

  • Computed Properties

  • Patents

Chemical Information

Synonyms N-acetyl-L-leucyl-L-α-glutamyl-L-histidyl-N-[2-oxo-4-(trifluoromethyl)-2H-1-benzopyran-7-yl]-L-α-asparagine; N-Acetyl-Leu-Glu-His-Asp-7-amino-4-Trifluoromethylcoumarin; Caspase-9 substrate; L-α-Asparagine, N-acetyl-L-leucyl-L-α-glutamyl-L-histidyl-N-[2-oxo-4-(trifluoromethyl)-2H-1-benzopyran-7-yl]-; (4S,7S,10S,13S)-10-((1H-imidazol-5-yl)methyl)-7-(2-carboxyethyl)-4-isobutyl-2,5,8,11-tetraoxo-13-((2-oxo-4-(trifluoromethyl)-2H-chromen-7-yl)carbamoyl)-3,6,9,12-tetraazapentadecan-15-oic acid
Purity ≥95%
IUPAC Name (4S)-4-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-5-[[(2S)-1-[[(2S)-3-carboxy-1-oxo-1-[[2-oxo-4-(trifluoromethyl)chromen-7-yl]amino]propan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
SMILES CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)O)C(=O)NC2=CC3=C(C=C2)C(=CC(=O)O3)C(F)(F)F)NC(=O)C
InChI InChI=1S/C33H38F3N7O11/c1-15(2)8-22(39-16(3)44)31(52)41-21(6-7-26(45)46)29(50)42-23(9-18-13-37-14-38-18)32(53)43-24(12-27(47)48)30(51)40-17-4-5-19-20(33(34,35)36)11-28(49)54-25(19)10-17/h4-5,10-11,13-15,21-24H,6-9,12H2,1-3H3,(H,37,38)(H,39,44)(H,40,51)(H,41,52)(H,42,50)(H,43,53)(H,45,46)(H,47,48)
InChIKey HULKIXRFKRCRHD-ZJZGAYNASA-N
Solubility Soluble in DMF, DMSO
Density 1.457±0.06 g/cm3 (Predicted)
Appearance Slightly Yellow Powder
Boiling Point 1211.9±65.0°C (Predicted)

Product Specification

Excitation 400 nm
Emission 505 nm
Storage Store at -20°C

Application

Computed Properties

XLogP3 0.2
Hydrogen Bond Donor Count 8
Hydrogen Bond Acceptor Count 15
Rotatable Bond Count 18
Exact Mass 765.25813954 g/mol
Monoisotopic Mass 765.25813954 g/mol
Topological Polar Surface Area 275Ų
Heavy Atom Count 54
Formal Charge 0
Complexity 1480
Isotope Atom Count 0
Defined Atom Stereocenter Count 4
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes

Patents

Publication Number Title Priority Date
US-2016058847-A1 IS100- A Highly Effective Enzyme Principle For Use In Dermal Therapeutics, And For Health And Beauty 2014-09-03
WO-2004100888-A2 N-thiolated azetidinones and anti-cancer use thereof 2003-05-06
US-2004167115-A1 Methods for preventing and treating cancer using N-thiolated beta-lactam compounds and analogs thereof 2002-05-06
US-2006160787-A1 Methods for preventing and treating cancer using N-thiolated beta-lactam compounds and analogs thereof 2002-05-06
US-7026472-B2 Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof 2002-05-06

Recommended Services

Recommended Articles

Recommended Products

Online Inquiry

Verification code
cartIcon
Inquiry Basket